Deutsche Bank’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7
Closed 4992
2019
Q4
$0 Hold
7
﹤0.01% 5191
2019
Q3
$0 Sell
7
-1,769
-100% -$12.2K ﹤0.01% 5395
2019
Q2
$11K Buy
1,776
+1,669
+1,560% +$12.7K ﹤0.01% 4965
2019
Q1
$1K Buy
107
+91
+569% +$906 ﹤0.01% 5126
2018
Q4
$0 Sell
16
-2,201
-99% -$31.7K ﹤0.01% 5510
2018
Q3
$43K Sell
2,217
-7,785
-78% -$142K ﹤0.01% 4752
2018
Q2
$181K Sell
10,002
-129,994
-93% -$1.92M ﹤0.01% 4330
2018
Q1
$1.49M Buy
139,996
+71,405
+104% +$1.15M ﹤0.01% 3066
2017
Q4
$2.89M Buy
68,591
+4,485
+7% +$201K ﹤0.01% 2476
2017
Q3
$3.53M Buy
64,106
+51,145
+395% +$8.63M ﹤0.01% 2136
2017
Q2
$2.4M Buy
12,961
+12,141
+1,481% +$2.13M ﹤0.01% 2438
2017
Q1
$96K Sell
820
-1,005
-55% -$105K ﹤0.01% 3933
2016
Q4
$180K Sell
1,825
-3,503
-66% -$369K ﹤0.01% 3740
2016
Q3
$596K Buy
5,328
+4,174
+362% +$501K ﹤0.01% 3109
2016
Q2
$117K Buy
1,154
+882
+324% +$88.2K ﹤0.01% 4029
2016
Q1
$24K Sell
272
-17,001
-98% -$1.81M ﹤0.01% 4587
2015
Q4
$2.49M Buy
17,273
+16,784
+3,432% +$2.18M ﹤0.01% 2287
2015
Q3
$50K Buy
+489
New +$57.3K ﹤0.01% 4451

Other funds holding SIOX

Deutsche Bank's SIOX Position: Q1 2020 in Review

Deutsche Bank sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2020, closing a stake of 7 shares.

Deutsche Bank first reported a position in SIOX in Q3 2015 and held it in 18 quarters. The position peaked at $3.53M in Q3 2017. 42 funds tracked by Wall St. Rank hold SIOX as of Q1 2020.

  • Deutsche Bank reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 7 Sio Gene Therapies Inc. Common Stock shares in Q1 2020.
  • Deutsche Bank first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 18 quarters.
  • Deutsche Bank's Sio Gene Therapies Inc. Common Stock position peaked at $3.53M in Q3 2017.
  • 42 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.